PortalPublikationenLigaSure™ vs. conventional dissection techniques in pancreat...

LigaSure™ vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial.

Standard

LigaSure™ vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial. / Uzunoglu, Faik Guentac; Bockhorn, Maximilian; Fink, Judith Alexandra; Reeh, Matthias; Vettorazzi, Eik; Gawad, Karim Abdel; Bogoevski, Dean; Vashist, Yogesh Kumar; Tsui, Tung Yu; Koenig, Alexandra; Mann, Oliver; Izbicki, Jakob Robert.

in: J GASTROINTEST SURG, Jahrgang 17, Nr. 3, 3, 2013, S. 494-500.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Uzunoglu, FG, Bockhorn, M, Fink, JA, Reeh, M, Vettorazzi, E, Gawad, KA, Bogoevski, D, Vashist, YK, Tsui, TY, Koenig, A, Mann, O & Izbicki, JR 2013, 'LigaSure™ vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial.', J GASTROINTEST SURG, Jg. 17, Nr. 3, 3, S. 494-500. https://doi.org/10.1007/s11605-012-2107-z

APA

Uzunoglu, F. G., Bockhorn, M., Fink, J. A., Reeh, M., Vettorazzi, E., Gawad, K. A., Bogoevski, D., Vashist, Y. K., Tsui, T. Y., Koenig, A., Mann, O., & Izbicki, J. R. (2013). LigaSure™ vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial. J GASTROINTEST SURG, 17(3), 494-500. [3]. https://doi.org/10.1007/s11605-012-2107-z

Vancouver

Uzunoglu FG, Bockhorn M, Fink JA, Reeh M, Vettorazzi E, Gawad KA et al. LigaSure™ vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial. J GASTROINTEST SURG. 2013;17(3):494-500. 3. https://doi.org/10.1007/s11605-012-2107-z

Bibtex

@article{31885aaf78ed42739b57ea54d4a8ffea,
title = "LigaSure{\texttrademark} vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial.",
abstract = "BACKGROUND: Surgical procedures in pancreatic surgery are well established, but still involve time-consuming manual dissection. We compared the use of LigaSure with conventional dissection techniques in pancreatic surgery in a prospective randomised single-centre trial (registration number: NCT00850291).METHODS: Patients with tumours of the pancreatic head that were assumed to be technically resectable were randomised to LigaSure or conventional surgery. The primary endpoint of this study was overall operation time. Secondary endpoints were preparation time until tumour resection, intraoperative blood loss, number of given units of packed red blood cells, costs of surgery, postoperative morbidity, length of hospital stay and mortality.RESULTS: There was no difference in overall operation time between the two groups (P = 0.227). Median costs for pancreatic surgery were significantly less in the conventional group with €3,047 (range 2,004-5,543) vs. €3,527 (range 2,516-5,056, P = 0.009). Preparation time, intraoperative blood loss, number of units of packed red blood cells, postoperative morbidity, length of hospital stay and mortality did not differ between the two groups.CONCLUSION: Our data indicate that the LigaSure device is equivalent to conventional dissection modalities in pancreatic surgery.",
keywords = "Adult, Aged, Aged, 80 and over, Blood Loss, Surgical, Dissection, Erythrocyte Transfusion, Female, Health Care Costs, Humans, Male, Middle Aged, Operative Time, Pancreatic Neoplasms, Preoperative Care, Statistics, Nonparametric, Time Factors, Treatment Outcome",
author = "Uzunoglu, {Faik Guentac} and Maximilian Bockhorn and Fink, {Judith Alexandra} and Matthias Reeh and Eik Vettorazzi and Gawad, {Karim Abdel} and Dean Bogoevski and Vashist, {Yogesh Kumar} and Tsui, {Tung Yu} and Alexandra Koenig and Oliver Mann and Izbicki, {Jakob Robert}",
year = "2013",
doi = "10.1007/s11605-012-2107-z",
language = "English",
volume = "17",
pages = "494--500",
journal = "J GASTROINTEST SURG",
issn = "1091-255X",
publisher = "Springer New York",
number = "3",

}

RIS

TY - JOUR

T1 - LigaSure™ vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial.

AU - Uzunoglu, Faik Guentac

AU - Bockhorn, Maximilian

AU - Fink, Judith Alexandra

AU - Reeh, Matthias

AU - Vettorazzi, Eik

AU - Gawad, Karim Abdel

AU - Bogoevski, Dean

AU - Vashist, Yogesh Kumar

AU - Tsui, Tung Yu

AU - Koenig, Alexandra

AU - Mann, Oliver

AU - Izbicki, Jakob Robert

PY - 2013

Y1 - 2013

N2 - BACKGROUND: Surgical procedures in pancreatic surgery are well established, but still involve time-consuming manual dissection. We compared the use of LigaSure with conventional dissection techniques in pancreatic surgery in a prospective randomised single-centre trial (registration number: NCT00850291).METHODS: Patients with tumours of the pancreatic head that were assumed to be technically resectable were randomised to LigaSure or conventional surgery. The primary endpoint of this study was overall operation time. Secondary endpoints were preparation time until tumour resection, intraoperative blood loss, number of given units of packed red blood cells, costs of surgery, postoperative morbidity, length of hospital stay and mortality.RESULTS: There was no difference in overall operation time between the two groups (P = 0.227). Median costs for pancreatic surgery were significantly less in the conventional group with €3,047 (range 2,004-5,543) vs. €3,527 (range 2,516-5,056, P = 0.009). Preparation time, intraoperative blood loss, number of units of packed red blood cells, postoperative morbidity, length of hospital stay and mortality did not differ between the two groups.CONCLUSION: Our data indicate that the LigaSure device is equivalent to conventional dissection modalities in pancreatic surgery.

AB - BACKGROUND: Surgical procedures in pancreatic surgery are well established, but still involve time-consuming manual dissection. We compared the use of LigaSure with conventional dissection techniques in pancreatic surgery in a prospective randomised single-centre trial (registration number: NCT00850291).METHODS: Patients with tumours of the pancreatic head that were assumed to be technically resectable were randomised to LigaSure or conventional surgery. The primary endpoint of this study was overall operation time. Secondary endpoints were preparation time until tumour resection, intraoperative blood loss, number of given units of packed red blood cells, costs of surgery, postoperative morbidity, length of hospital stay and mortality.RESULTS: There was no difference in overall operation time between the two groups (P = 0.227). Median costs for pancreatic surgery were significantly less in the conventional group with €3,047 (range 2,004-5,543) vs. €3,527 (range 2,516-5,056, P = 0.009). Preparation time, intraoperative blood loss, number of units of packed red blood cells, postoperative morbidity, length of hospital stay and mortality did not differ between the two groups.CONCLUSION: Our data indicate that the LigaSure device is equivalent to conventional dissection modalities in pancreatic surgery.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Blood Loss, Surgical

KW - Dissection

KW - Erythrocyte Transfusion

KW - Female

KW - Health Care Costs

KW - Humans

KW - Male

KW - Middle Aged

KW - Operative Time

KW - Pancreatic Neoplasms

KW - Preoperative Care

KW - Statistics, Nonparametric

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1007/s11605-012-2107-z

DO - 10.1007/s11605-012-2107-z

M3 - SCORING: Journal article

C2 - 23250820

VL - 17

SP - 494

EP - 500

JO - J GASTROINTEST SURG

JF - J GASTROINTEST SURG

SN - 1091-255X

IS - 3

M1 - 3

ER -